Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X:

“Congratulations and thank you Sebastian Mondaca on superb valuable effort for Chile. Memorial Sloan Kettering Cancer Center, MSK Department of Medicine, Ghassan Abou-Alfa and team are proud for contributing to ERBB2-altered gallbladder cancer characterization in Chile!”

Clinical and genomic characterization of ERBB2-altered gallbladder cancer

Authors:  Sebastian Mondaca, Nikolaus Schultz, Juan Carlos Roa, Henry S. Walch, Santiago Sepulveda, James J.              Harding, Amin Yaqubie, Patricia Garcia, Gloria Aguayo, Bruno Nervi, Bob T. Li and  Ghassan K. Abou-Alfa.